LISA GARCES: Open Payments
NPI 1114118577 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 9 payments from 9 companies in 2025. Trend: 2023 $83 · 2024 $42 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $26 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| SOBI, INC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: BLENREP, Phyrago, Xospata, Vonjo, PREVYMIS, Venclexta, TAVALISSE, JAKAFI.
Industry payments across NC — which companies pay providers there.
